These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32676896)

  • 21. KM55 in the Evaluation of IgA-Containing Glomerular Diseases.
    Raj R; Sharma A; Barwad A; Bagchi S; Agarwal SK; Bagga A; Dinda AK; Singh G
    Glomerular Dis; 2022 Apr; 2(2):59-74. PubMed ID: 36751531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report on mesangial proliferative glomerulonephritis with multicentric Castleman's disease: Approach to the onset mechanism of immunoglobulin A nephropathy.
    Karasawa K; Ogura S; Miyabe Y; Akiyama K; Nitta K; Moriyama T
    Clin Immunol; 2020 Mar; 212():108347. PubMed ID: 31978558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report.
    Sugai K; Ueda H; Morimoto K; Tanaka M; Takahashi D; Nakashima A; Kato J; Takahashi H; Yamaguchi Y; Kawamura T; Hanaoka K; Miyazaki Y; Yokoo T
    BMC Nephrol; 2018 Dec; 19(1):350. PubMed ID: 30526529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation.
    Kawabe M; Yamamoto I; Yamakawa T; Katsumata H; Isaka N; Katsuma A; Nakada Y; Kobayashi A; Koike K; Ueda H; Tanno Y; Koike Y; Miki J; Yamada H; Kimura T; Ohkido I; Tsuboi N; Yamamoto H; Kojima H; Yokoo T
    Front Immunol; 2020; 11():2068. PubMed ID: 33013875
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapid progression to end-stage renal disease in a child with IgA-dominant infection-related glomerulonephritis associated with parvovirus B19.
    Shirai Y; Miura K; Yabuuchi T; Nagasawa T; Ishizuka K; Takahashi K; Taneda S; Honda K; Yamaguchi Y; Suzuki H; Suzuki Y; Hattori M
    CEN Case Rep; 2020 Nov; 9(4):423-430. PubMed ID: 32621069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
    Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
    J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological and histopathological assessment of galactose-deficient immunoglobulin A1 deposition in kidney allografts: A multicenter prospective observational study.
    Sofue T; Oguchi H; Yazawa M; Tsujita M; Futamura K; Nishihira M; Toyoda M; Kano T; Suzuki H
    PLoS One; 2023; 18(2):e0281945. PubMed ID: 36795799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune characteristics of renal allograft donors with mesangial IgA deposition.
    Wang Z; Zhang X; Han W; Yu G; Ying Z; Xu X; Wang M; Zhou X; Lv J; Zhang H
    Int Immunopharmacol; 2021 Feb; 91():107282. PubMed ID: 33370682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
    Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
    PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn's disease.
    Terasaka T; Uchida HA; Umebayashi R; Tsukamoto K; Tanaka K; Kitagawa M; Sugiyama H; Tanioka H; Wada J
    BMC Nephrol; 2016 Sep; 17(1):122. PubMed ID: 27596164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change.
    Cho WH; Park SH; Choi SK; Jung SW; Jeong KH; Kim YG; Moon JY; Lim SJ; Sung JY; Jhee JH; Chin HJ; Choi BS; Lee SH
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32806730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
    Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.
    Schmitt R; Ståhl AL; Olin AI; Kristoffersson AC; Rebetz J; Novak J; Lindahl G; Karpman D
    J Immunol; 2014 Jul; 193(1):317-26. PubMed ID: 24850720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1.
    Hu SL; Colvin GA; Rifai A; Suzuki H; Novak J; Esparza A; Farooqi S; Julian BA
    Nephrol Dial Transplant; 2010 May; 25(5):1708-13. PubMed ID: 20067905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to treat patients with chronic kidney disease: With special focus on IgA nephropathy.
    Tomino Y
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():76-79. PubMed ID: 30298660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy.
    Misaki T; Naka S; Suzuki H; Lee M; Aoki R; Nagasawa Y; Matsuoka D; Ito S; Nomura R; Matsumoto-Nakano M; Suzuki Y; Nakano K
    PLoS One; 2023; 18(3):e0282367. PubMed ID: 36862654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy.
    Fukao Y; Suzuki H; Kim JS; Jeong KH; Makita Y; Kano T; Nihei Y; Nakayama M; Lee M; Kato R; Chang JM; Lee SH; Suzuki Y
    J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of paraneoplastic IgA nephropathy with glomerular capillary IgA and galactose-deficient IgA1 deposition.
    Isogai E; Iwazu Y; Akimoto T; Kuro-O M; Niki T; Nagata D
    CEN Case Rep; 2024 Apr; 13(2):104-109. PubMed ID: 37434086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.